Matthew G Manders
CIK 1480601 · Pres, Government and Solutions · last filed 2025-10-06
Matthew G Manders is a Pres, Government and Solutions who has filed 47 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing, for BHG, was dated Oct 6, 2025. Across all open-market trades the lifetime net is −$24.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
TWO LIBERTY PLACE
PHILADELPHIA, PA 19192
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NeueHealth, Inc. (BHG) Delisted | Director | 0 | $16.35 | $0 | $0 | 3 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | Director | 16,741 | $6.75 | $113.1K | $0 | 2 | 2025-05-15 |
| CI | Pres, Government and Solutions | 43,488 | $306.95 | $13.35M | -$23.95M | 41 | 2021-11-23 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-06 | NeueHealth, Inc. (BHG) Delisted | Disp (D) | −16,741 | $0 | EDGAR |
| 2025-05-15 | NeueHealth, Inc. (NEUE) Delisted | Exer (M) | +10,500 | $0 | EDGAR |
| 2024-05-14 | NeueHealth, Inc. (NEUE) Delisted | Mixed | +4,755 | $0 | EDGAR |
| 2023-05-16 | NeueHealth, Inc. (BHG) Delisted | Mixed | +118,886 | $0 | EDGAR |
| 2022-05-17 | NeueHealth, Inc. (BHG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-23 | CI | Tax (F) | −1,081 | -$231.0K | EDGAR |
| 2021-03-02 | CI | Mixed | −1,072 | -$1.36M | EDGAR |
| 2021-02-26 | CI | Grant (A) | +5,219 | $0 | EDGAR |
| 2021-01-25 | CI | Sell (S) | −5,596 | -$1.29M | EDGAR |
| 2020-03-02 | CI | Mixed | −548 | -$1.25M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.